Author: Heinz HuberPublisher:
ISBN: 9780387090696
Category : Cancer
Languages : de
Pages : 209
Book Description
Adjuvante zytostatische Chemotherapie
Author: Heinz HuberPublisher:
ISBN: 9780387090696
Category : Cancer
Languages : de
Pages : 209
Book Description
Adjuvante Zytostatische Chemotherapie
Author: Deutschen und Osterreichischen Gesellschaft fur Hamatologie und OnkologiePublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Adjuvante zytostatische Chemotherapie
Author: Deutsche Gesellschaft für Hämatologie und OnkologiePublisher: Springer
ISBN:
Category : Medical
Languages : de
Pages : 240
Book Description
Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie und Onkologie, 13. - 16. November 1977 in Linz
Adjuvant Chemotherapy of Breast Cancer
Author: Hans-Jörg SennPublisher: Springer Science & Business Media
ISBN: 3642823572
Category : Medical
Languages : en
Pages : 302
Book Description
H.-J. Senn Adjuvant Chemotherapy (ACT) of breast cancer has now emerged as one of the controversial su):>jects in clinical and also experimental oncology. Driven by growing frustration about stagnating cure rates in breast cancer [1,4] and stimulated by elegant demonstration of highly curative effects of adjuvant systemic therapy in animal models [6, 11] and in several childhood neoplasias [15], researchers introduced ACT to the primary treatment of breast cancer with great hope some 15 years ago. After a first wave of isolated "historic" trials with generally limited but in one case remarkable success [5, 9], a second generation of ACT studies was initiated by NSABP investigators and oncology centers in Europe [2, 6, 13]. These trials were well conducted statistically and diagnostically, and all in the early 1970s included a surgical control arm. Early and intermediate beneficial effects on relapse-free survival (RFS) after 2-3 years median observation time then prompted a whole series of ACT studies in breast cancer. These "third-gener ation" studies usually regarded some positive influence of ACT as a given fact, dropping surgical control regimens and comparing different ACT regimens, hopefully in a prospective, randomized way 1984 Fig. 1. The mushrooming of adjuvant studies in breast cancer XII Introduction [reviews in 3, 14]. The "mushrooming" of ACT studies in breast cancer during the last 10 and especially 5 years is demonstrated in Fig. 1, and it gets really cumbersome even for the insider to keep on top of the multitude of sometimes conflicting data.
Hemostasis and Cancer
Author: Laszlo MuszbekPublisher: CRC Press
ISBN: 1000013308
Category : Medical
Languages : en
Pages : 297
Book Description
First Published in 1987: The book is to give insight into the multisided relationship of hemostatic systems and malignancies and to help biomedical scientists and practicing clinicians obtain a better understanding of cancer research.
Surgical Treatment of Bronchial Carcinoma
Author: J. HassePublisher: Springer Science & Business Media
ISBN: 364270977X
Category : Medical
Languages : en
Pages : 168
Book Description
If a consecutive series of patients with lung cancer is followed up until the decision is made about therapy, it emerges that the role of surgery is quite small. Only a very limited proportion will ultimate ly qualify for rationally conceived surgical therapy; most patients are inoperable. In a series of 397 patients investigated at our hospi tal, 78% were inoperable on the basis of preoperative evaluation and a further 3% proved nonresectable at thoracotomy; therefore, only 19% were suitable for resection. On the other hand, surgery is still thought to offer the best, if not the only realistic chance of cure. The question "operable or not?" is therefore of vital importance for the individual patient. The answer to this crucial question must be based on valid guidelines for pa tient selection and preoperative evaluation, and it should be clearly defined what extent of resection is necessary in order to realize any curative intention. In 1972 a thorough analysis of the literature revealed that re section of bronchial carcinoma - although 40 years old - was being undertaken with very variable indications. There was hardly any systematic staging, and assessment of results was hampered by the fact that most communications in the literature were based on retrospective analysis.
Author: 
Author: 
Author: 
Author: